Associated Papers
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.
Wolff JH et al.
Nature Communications, 2025
40796771 (PubMed )
Supplement: 41467_2025_62738_MOESM1_ESM.pdf
Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye.
Erman B et al.
Journal of Clinical Immunology, 2024
Characterization of missense mutations in the NADPH oxidase partner p22phox in the A22° subtype of chronic granulomatous disease.
Kawai C et al.
Microbiology and Immunology, 2023
CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.
Stasia MJ
Gene, 2016
Molecular basis of autosomal recessive chronic granulomatous disease in iran.
Teimourian S et al.
Journal of Clinical Immunology, 2010
Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).
Roos D et al.
Blood Cells, Molecules & Diseases, 2010
Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease.
Teimourian S et al.
British Journal of Haematology, 2008
Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
Mortaz E et al.
International Archives of Allergy and Immunology, 0
Select a paper to view details